hCG Activator
90/100
This product looks safe
- Contains proprietary blend — exact ingredient amounts not disclosed
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed
Label Data
1 Tablet(s)
Serving Size
120
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
16 mg
(100% DV)
✅ 1.1× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
Proprietary Blend
149 mg
Other Ingredients
Sorbitol
Microcrystalline Cellulose
Natural flavor
Stearic Acid
Citric Acid
Vegetable Magnesium Stearate
Silicon
Croscarmellose Sodium
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Women (not pregnant or lactating)
Product Information
📋 Directions for Use
Suggested Use: Take one tablet, three times daily during maintenance phase. Allow tablet to dissolve under the tongue.
⚠️ Warnings & Precautions
Warning: Do not use when pregnant or nursing.
Not for use by persons under 18 years of age.
Do not use without consulting your health care professional, if you have any existing medical condition. Do not exceed recommended dosage.
Keep out of reach of children.
Product Details
UPC / SKU
8 18423 02059 4
DSLD Entry Date
2021-10-22
Product Type
Other Combinations
Form
Tablet or Pill
Brand
Biomedx Research
DSLD ID
256671
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100